Australia BlinkLab rises on partnership with INTER-PSY

BlinkLab

12/09/2024 02:44

** Shares of BlinkLab  BB1.AX  rise as much as 11.9% to
A$0.235, their highest level since Sept 5
    ** Digital healthcare co announces research and clinical
partnership with INTER-PSY in the Netherlands
    ** As part of agreement, INTER-PSY will run a prospective
study on the ability of BlinkLab app to aid in diagnosis of
autism in children between 2-6 years of age - BlinkLab
    ** Partnership will accelerate BlinkLab's path to the U.S.
and European regulatory approvals for autism and clinical
adoption - co
    ** Stock had fallen 20.8% since its April 4 debut, as of
Wednesday's close

 (Reporting by Sherin Sunny in Bengaluru)
 ((Sherin.Sunny@thomsonreuters.com))